An IDIBAPS team identifies a molecular interaction that drives the aggressiveness of lymphoma and proposes a new therapeutic strategy to combat it.
"La Caixa" Foundation will allocate €150,000 to the project led by Alba Rodríguez, from the IDIBAPS Cellular Immunotherapies for Cancer research gr...
IDIBAPS is opening a call for up to 9 predoctoral fellowships in biomedicine, funded by the “Agencia Estatal de Investigación”. This proposal is ai...
A team led by Joan-Marc Servitja, from the IDIBAPS Pathogenesis and Prevention of Diabetes research group, has demonstrated in mouse models that hi...
Reducing aspirin to one month after a heart attack lowers bleeding risk without increasing cardiovascular complications.
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrat...
A systematic review published in eClinicalMedicine concludes that most antidepressants, when used appropriately, do not significantly increase the...
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a st...
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic m...
An international team led by the Clínic-IDIBAPS and the Institute of Cancer Research in London has developed an innovative new method based on DNA...